CLB 📈 Core Laboratories - Overview
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: NL0000200384
CLB: Laboratory, Analytical, Testing, Services, Reservoir, Enhancement, Products
Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas. Web URL: https://www.corelab.com
Additional Sources for CLB Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CLB Stock Overview
Market Cap in USD | 955m |
Sector | Energy |
Industry | Oil & Gas Equipment & Services |
GiC Sub-Industry | Oil & Gas Equipment & Services |
IPO / Inception | 1995-09-20 |
CLB Stock Ratings
Growth 5y | -45.7% |
Fundamental | 30.3% |
Dividend | 13.3% |
Rel. Strength Industry | -488 |
Analysts | 2.71/5 |
Fair Price Momentum | 14.25 USD |
Fair Price DCF | 24.08 USD |
CLB Dividends
Dividend Yield 12m | 0.24% |
Yield on Cost 5y | 0.09% |
Annual Growth 5y | -55.13% |
Payout Consistency | 85.9% |
CLB Growth Ratios
Growth Correlation 3m | 35.8% |
Growth Correlation 12m | 72.2% |
Growth Correlation 5y | -37.2% |
CAGR 5y | -18.28% |
CAGR/Mean DD 5y | -0.36 |
Sharpe Ratio 12m | -0.08 |
Alpha | -36.02 |
Beta | 1.14 |
Volatility | 45.01% |
Current Volume | 1101.2k |
Average Volume 20d | 324.9k |
What is the price of CLB stocks?
As of December 21, 2024, the stock is trading at USD 16.85 with a total of 1,101,233 shares traded.
Over the past week, the price has changed by -13.32%, over one month by -17.04%, over three months by -9.26% and over the past year by -8.31%.
As of December 21, 2024, the stock is trading at USD 16.85 with a total of 1,101,233 shares traded.
Over the past week, the price has changed by -13.32%, over one month by -17.04%, over three months by -9.26% and over the past year by -8.31%.
Is Core Laboratories a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Core Laboratories is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 30.33 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CLB as of December 2024 is 14.25. This means that CLB is currently overvalued and has a potential downside of -15.43%.
Neither. Based on ValueRay Fundamental Analyses, Core Laboratories is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 30.33 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CLB as of December 2024 is 14.25. This means that CLB is currently overvalued and has a potential downside of -15.43%.
Is CLB a buy, sell or hold?
Core Laboratories has received a consensus analysts rating of 2.71. Therefor, it is recommend to hold CLB.
Core Laboratories has received a consensus analysts rating of 2.71. Therefor, it is recommend to hold CLB.
- Strong Buy: 0
- Buy: 1
- Hold: 4
- Sell: 1
- Strong Sell: 1
What are the forecast for CLB stock price target?
According to ValueRays Forecast Model, CLB Core Laboratories will be worth about 15.8 in December 2025. The stock is currently trading at 16.85. This means that the stock has a potential downside of -6.41%.
According to ValueRays Forecast Model, CLB Core Laboratories will be worth about 15.8 in December 2025. The stock is currently trading at 16.85. This means that the stock has a potential downside of -6.41%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 20 | 18.7% |
Analysts Target Price | 23.3 | 38% |
ValueRay Target Price | 15.8 | -6.4% |